What is a lung nodule and how is it treated?
A lung nodule is a small spot in the lung that is usually benign, but about one in five turns out to be cancer, so doctors compare old scans and tailor follow-up to the risk.
Covers: What a lung nodule is, how it appears on imaging, how doctors assess its risk of cancer, and the main management options from monitoring to surgery. It does not cover specific individual diagnoses or detailed treatment protocols for confirmed lung cancer.
Also answers: What is a lung nodule? · Lung nodule meaning and treatment · Are lung nodules serious? · How are lung nodules treated?
- One page for this question6 other ways of asking lead here
- 6 independent sourcesEvery claim links to what supports it
- Joins the mapLinked as related pages appear
- Clean discussionScreened before anything appears

The short answer
Evidence-backed AI-prepared starting mapA lung nodule (pulmonary nodule) is a relatively small focal density in the lung. A solitary pulmonary nodule is a mass in the lung smaller than 3 cm in diameter; lesions larger than that are termed masses, and a pulmonary micronodule is under 3 mm. Nodules are frequently found incidentally — in up to 0.2% of chest X-rays and around 1% of CT scans — and most commonly represent a benign tumour such as a granuloma or hamartoma, though roughly 20% turn out to be malignant, especially in older adults and smokers. Conversely, 10–20% of people with lung cancer are diagnosed this way. Evaluation centres on comparing current with previous imaging where available, because stability over time is a key signal of benignity.123
- Evidence 24
Did this answer your question?
Be the first to voteIn brief
Most nodules are benign (granuloma or hamartoma), but around 20% are malignant, especially in older adults and smokers; 10–20% of lung cancers are found this way.1
Evidence-backedComparing with previous imaging is essential: solid nodules stable for 2 years are considered benign, while subsolid nodules need longer stability and carry higher malignancy risk if a solid component develops or enlarges.3
Evidence-backedManagement is risk-stratified: CT surveillance for low-risk nodules, PET-CT and/or biopsy for intermediate-risk, and surgery for selected high-risk nodules.3
Evidence-backedThe goal is to diagnose cancer promptly while avoiding unnecessary invasive procedures in people with benign disease.3
Evidence-backed
At a glance
The picture in numbers
Live · updated just now
- chest X-rays0.2%
- CT scans1%
10–20%
The high estimate is 2 times the low one.
under 3 mm
micronodule
under 3 cm
nodule
3 cm and larger
mass
The evidence behind it
6 sources- Reviews of many studies2
- Other studies and data1
- Background3
Published in 2026
| Source | Kind | Year |
|---|---|---|
| Pulmonary Nodules. | Other studies and data | 2026 |
| Biology, detection, and management of incidental pulmonary nodules: the emerging role of targeted treatments. A review of the current literature and future perspectives. | Reviews of many studies | 2026 |
| Systematic review and single-arm meta-analysis of the clinical value of multidisciplinary team-based multimodal interventions in pulmonary nodule management. | Reviews of many studies | 2026 |
| Nodule (medicine) (Wikipedia) | Background | Unknown |
| Lung nodule (Wikipedia) | Background | Unknown |
| Pope Leo to have surgery after lump found on lung | Background | 2026 |
The community around it
No one has added to this page yet. Firsthand experience, a newer study or a different reading of the numbers would show up here, credited to you.
Shares and multiples are worked out from the figures the page states.
What it means for you
Which fits you?
Pick the situation closest to yours. Each answer says what it rests on.
If a nodule is found incidentally on a chest X-ray or CT
it is usually benign, but the possibility of cancer needs to be assessed, especially if you are older or have smoked.1
Evidence-backedIf previous imaging of the same nodule is available
comparing the two is essential to judge malignancy risk; a solid nodule unchanged for 2 years is considered benign.3
Evidence-backedIf the nodule is subsolid
expect a longer period of stability before it is called benign, and more concern if a solid component appears or grows.3
Evidence-backedIf the nodule is judged low risk
CT surveillance is the indicated approach.3
Evidence-backedIf the nodule is judged intermediate risk
PET-CT, biopsy, or both are indicated; biopsy options include transthoracic needle biopsy and navigational bronchoscopy.3
Evidence-backedIf the nodule is selected as high risk
surgical resection may be offered.3
Evidence-backedIf you have a history of smoking or the nodule is growing
further radiological studies and interventions may be needed to exclude cancer, possibly including surgical resection.1
Evidence-backedIf your care is managed by a multidisciplinary team
reported outcomes include a pooled positive predictive value of 0.766 and a pooled early-stage (I–II) proportion of 0.741 among diagnosed cases, though these estimates are imprecise and come from single-arm studies.5
Evidence-backedThe full story · 4 chapters
01
What a lung nodule is
AI summary:A lung nodule is a focal lung opacity under 3 cm, often found incidentally, and most are benign though about 20% are malignant.
Evidence-backed: In medicine generally, a nodule is a small, discrete lump or growth that differs from surrounding tissue; definitions vary by specialty. In pulmonology, when the lungs are imaged by radiography, a nodule is a round, focal opacity in lung tissue of less than 3 cm in diameter, with larger lesions instead called masses. A solitary pulmonary nodule (sometimes called a coin lesion) is a mass in the lung smaller than 3 cm; a pulmonary micronodule is under 3 mm. There may also be multiple nodules.21
Evidence-backed: Nodules are often detected by medical imaging and can be benign or malignant. One or more lung nodules can be an incidental finding in up to 0.2% of chest X-rays and around 1% of CT scans. Incidental detection is increasing because of advances in imaging techniques and wider use of CT for thoracic evaluation.14
Evidence-backed: The nodule most commonly represents a benign tumour such as a granuloma or hamartoma, but in around 20% of cases it represents a malignant cancer, especially in older adults and smokers. Conversely, 10 to 20% of patients with lung cancer are diagnosed in this way. The prognosis depends on the underlying condition.1
02
How the risk of cancer is assessed
AI summary:Comparing current with previous imaging is essential, since stability suggests benignity while subsolid nodules and growth raise cancer risk.
Evidence-backed: Comparison of current and previous imaging studies, when available, is essential to assess the risk of the nodule being malignant. Solid nodules that have been stable for 2 years are considered benign, whereas subsolid nodules require a longer period of stability to be considered benign. Prediction models to stratify the risk of malignancy can be used to guide management of solid nodules.3
Evidence-backed: Subsolid nodules are often slower growing than solid nodules but are associated with a higher risk of being malignant, especially if a solid component develops or progressively enlarges. If the patient has a history of smoking or the nodule is growing, the possibility of cancer may need to be excluded through further radiological studies and interventions, possibly including surgical resection.31
Evidence-backed: Distinguishing benign from malignant incidental nodules is key to improving lung cancer outcomes, since lung cancer is the leading cause of cancer-related deaths globally and early diagnosis and treatment improve prognosis. Current management guidelines differ by nodule type and involve biopsy to determine the malignancy status of the nodule.4
03
Management options, from monitoring to surgery
AI summary:Management is risk-stratified from CT surveillance to PET-CT, biopsy, or surgery, aiming to catch cancer early without unnecessary procedures.
Evidence-backed: Management strategies differ according to the type of nodule. CT surveillance is indicated for low-risk nodules; positron-emission tomography-CT, biopsy, or both for intermediate-risk nodules; and surgical resection for selected high-risk nodules. Biopsy methods include transthoracic needle biopsy and navigational bronchoscopy. Optimal overall management balances timely diagnosis in persons who have cancer with the avoidance of unnecessary invasive procedures in persons who have benign disease.3
Evidence-backed: A systematic review and single-arm meta-analysis of multidisciplinary team (MDT)-based multimodal interventions reported a pooled positive predictive value of 0.766 (95% CI 0.643–0.913), a pooled guideline adherence rate of 0.766 (95% CI 0.386–0.945), a pooled lung cancer diagnosis rate of 0.120 (95% CI 0.053–0.210), and a pooled proportion of early-stage (I–II) lung cancer among diagnosed cases of 0.741 (95% CI 0.422–0.918). Qualitative synthesis suggested MDT-based management may contribute to reducing unnecessary benign pulmonary nodule resection in selected clinical settings. The authors conclude that further well-designed comparative studies are needed.5
Evidence-backed: Research is also examining the role of oncogenic driver mutations in the pathobiology of pulmonary nodules and the targeted treatment of oncogene-driven nodules, alongside evidence gaps and areas for future research.4
04
Recent news example
AI summary:A single 2026 news report described a pontiff whose lung nodule was found early and who planned surgery.
Evidence-backed: On 11 October 2026, BBC News reported that the 71-year-old pontiff said a nodule had been identified on his lung "at a very early stage" and that he would have surgery. This is a single reported case and does not by itself describe how nodules are generally evaluated or treated.6
Your turn
Have your say
See where others stand. Join free to add your perspective. One answer per account.
How do you feel about this?
No votes yetQuick questions from connected pages
Before you go
What to remember
Try to recall each hidden figure before you reveal it. Remembering, not rereading, is what makes it stick.
A lung nodule is a small focal density in the lung, under cm in diameter; larger lesions are called masses, and micronodules are under 3 mm.
Most nodules are benign (granuloma or hamartoma), but around are malignant, especially in older adults and smokers; 10–20% of lung cancers are found this way.
Comparing with previous imaging is essential: solid nodules stable for years are considered benign, while subsolid nodules need longer stability and carry higher malignancy risk if a solid component develops or enlarges.
Your reading
0 of 4 chaptersThis answer keeps changing
When new evidence or a better source comes in, this page is updated (it's on version 2, last changed 1 hour ago). Follow it to be told when that happens.
Ask this Sylo
Still wondering about something?
Answers come only from this page's reviewed material, with citations, and say plainly when the page doesn't cover it yet.
Behind this page
Who's adding to it, where it comes from, how it changed and what would make it better. Always open to everyone.
Discussion
Sources
Numbers match the citations in the article. A working link isn't proof that a page supports a claim; check the quoted passage and date.
- 1Lung nodule (Wikipedia)WikipediaPublished Sep 29, 2026Checked Oct 11, 2026
“A lung nodule or pulmonary nodule is a relatively small focal density in the lung. A solitary pulmonary nodule (SPN) or coin lesion, is a mass in the lung smaller than three centimeters in diameter. A pulmonary micronodule has a diameter of less than three millimetres. There may also be multiple nodules. One or more lung nodules can be an incidental finding found in up to 0.2% of chest X-rays and around 1% of CT scans. The nodule most commonly represents a benign tumor such as a granuloma or hamartoma, but in around 20% of cases it represents a malignant cancer, especially in older adults and smokers. Conversely, 10 to 20% of patients with lung cancer are diagnosed in this way. If the patient has a history of smoking or the nodule is growing, the possibility of cancer may need to be excluded through further radiological studies and interventions, possibly including surgical resection. The prognosis depends on the underlying condition.”
- 2Nodule (medicine) (Wikipedia)WikipediaPublished Sep 29, 2026Checked Oct 11, 2026
“In medicine, a nodule is a small, discrete lump or growth that is different from surrounding tissue. They are often detected by medical imaging and can be either benign or malignant. Definitions vary by medical specialty. In dermatology, nodules are usually greater than 1 cm in diameter, in contrast to raised, soft bumps of less than 1 cm, which are termed papules, and to cysts, which contain fluid. In pulmonology, when imaging the lungs by radiography, a nodule is a round, focal opacity in the lung tissue of less than 3 cm in diameter, with lesions larger than that instead termed masses. In endocrinology, a thyroid nodule is a lump formed by abnormal growth. Nodules in skin include dermatofibroma and pyogenic granuloma. Nodules may form on tendons and muscles in response to injury, and are frequently found on vocal cords. They may occur in organs such as the lung, or thyroid, or be a sign in other medical conditions such as rheumatoid arthritis.”
- 3Pulmonary Nodules.The New England journal of medicine (Callister & Silvestri)Published Sep 1, 2026Checked Oct 11, 2026
“Management strategies differ according to the type of nodule. A comparison of current and previous imaging studies, when available, is essential to assess the risk of the nodule being malignant. Solid nodules that have been stable for 2 years are considered to be benign, whereas subsolid nodules require a longer period of stability to be considered benign. Prediction models to stratify the risk of the nodule being malignant can be used to guide the management of solid nodules. Computed tomographic (CT) surveillance is indicated for low-risk nodules; positron-emission tomography-CT, biopsy, or both for intermediate-risk nodules; and surgical resection for selected high-risk nodules. Subsolid nodules are often slower growing than solid nodules but are associated with a higher risk of being malignant, especially if a solid component develops or progressively enlarges. Biopsy methods include transthoracic needle biopsy and navigational bronchoscopy. Optimal overall management balances timely diagnosis in persons who have cancer with the avoidance of unnecessary invasive procedures in persons who have benign disease.”
- 4Biology, detection, and management of incidental pulmonary nodules: the emerging role of targeted treatments. A review of the current literature and future perspectives.Lung cancer (Amsterdam, Netherlands) (Soo et al.)Published Aug 3, 2026Checked Oct 11, 2026
“Lung cancer is the leading cause of cancer-related deaths globally, and early diagnosis and treatment are important for improving prognosis. Pulmonary nodules (PNs) are small pulmonary lesions frequently identified during clinical practice, with incidental detection increasing due to advances in imaging techniques and the expanded use of computed tomography scans for thoracic evaluation. The majority of incidental PNs (IPNs) are benign, however some represent early-stage lung cancer, therefore distinguishing benign from malignant IPNs is key to improving lung cancer outcomes. Current management guidelines differ by nodule type and involve biopsy to determine the malignancy status of the nodule. Here, we review current knowledge on the classification, prevalence, and detection of PNs, as well as the current management and risk stratification of PNs. We outline the role of oncogenic driver mutations in the pathobiology of PNs and assess current literature on targeted treatment of oncogene-driven PNs. Finally, we discuss evidence gaps and areas for future research.”
- 5Systematic review and single-arm meta-analysis of the clinical value of multidisciplinary team-based multimodal interventions in pulmonary nodule management.Frontiers in oncology (Tong et al.)Published Jun 29, 2026Checked Oct 11, 2026
“The pooled positive predictive value (PPV) of MDT-based pulmonary nodule management was 0.766 (95% CI: 0.643-0.913). The pooled guideline adherence rate was 0.766 (95% CI: 0.386-0.945). The pooled lung cancer diagnosis rate was 0.120 (95% CI: 0.053-0.210), and the pooled proportion of early-stage (I-II) lung cancer among diagnosed cases was 0.741 (95% CI: 0.422-0.918). In addition, qualitative synthesis suggested that MDT-based management may contribute to reducing unnecessary benign pulmonary nodule resection in selected clinical settings.ConclusionMDT-based pulmonary nodule management programs were associated with relatively favorable reported outcomes in diagnostic-related metrics and guideline adherence across included studies. Further well-designed comparative studies are needed to validate these findings.Systematic review registrationhttps://www.crd.york.ac.uk/prospero/, identifier CRD420261295367.”
- 6Pope Leo to have surgery after lump found on lungBBC NewsPublished Oct 11, 2026Checked Oct 11, 2026
“The 71-year-old pontiff said the nodule was identified "at a very early stage".”
How it changed
Published 1 time since Oct 11, 2026.
- Version 2Oct 11, 2026Live now
AI-prepared Starting Map from live research.
- First published version.
Help improve it
The brief is open about what's uncertain. These are the specific gaps that new material would fill.
“Recent news example” rests on one independent source
A second, independent source that confirms or challenges it would make this part more reliable.
Open questions
How often does CT surveillance lead to anxiety, additional tests, or procedures for nodules that turn out to be benign?
No answers yet
Do multidisciplinary team programmes improve outcomes compared with usual care, and in which settings?
No answers yet
How long must subsolid nodules remain stable before they can be considered benign?
No answers yet
What is it like to live with a nodule under surveillance or to undergo biopsy, in patients' own accounts?
No answers yet
Around this topic
Sylos connect: narrower topics report up to broader ones, so what's learned in one place shows up where it matters.